- NYU Winthrop Physician Celebrates 100th UroLift® Procedure - A Revolutionary Approach to Treating Enlarged Prostate
- February 1, 2018
- Bayside resident Manuel Lago is thrilled with the outcome of the Urolift procedure he had with Dr. Jeffrey Schiff at NYU Winthrop Hospital.
Mineola, NY – When 69-year-old Manuel Lago found out there was a minimally invasive procedure to treat the debilitating effects of an enlarged prostate that had affected him for over 15 years, he was eager to learn more. Frequent nighttime trips to the bathroom as well as urinary tract infections (UTIs) left Mr. Lago aggravated and in pain. After much research and the expert guidance of his urologist, Jeffrey Schiff, MD, FACS, Attending Urologist at NYU Winthrop Hospital, the Bayside resident decided to undergo an in-office Urolift procedure with local anesthesia, performed by Dr. Schiff. Within days, he felt like a new person.
“It’s the best thing I have ever done!” exclaimed Mr. Lago. “I may be 69, but I feel like I’m 20 years old!”
An enlarged prostate, or Benign Prostatic Hyperplasia (BPH), can cause various difficulties in urinating, including frequent urination and UTIs, among other symptoms. The UroLift System® is the first permanent implant to treat symptoms of BPH in men 50 years of age or older. Approved by the U.S. Food and Drug Administration in 2013, the UroLift System is designed to relieve symptoms caused by an enlarged prostate, while preserving sexual function. Permanent implants act like window curtain tie-backs to hold the lobes of an enlarged prostate open, so the lobes no longer block the urethra. There is no cutting, burning or removal of prostate tissue. Patients recover from the procedure within just a few days and return to their normal routines with minimal downtime.The UroLift® System, a minimally invasive approach to treating BPH that lifts or holds the enlarged prostate tissue out of the way so it no longer blocks the urethra, is available at NYU Winthrop Hospital. There is no cutting, burning or removal of prostate tissue.
“NYU Winthrop Hospital remains committed to providing patients with the highest quality and most effective options to address a myriad of health and urology needs,” said Dr. Schiff, who was the first physician to complete an in-office Urolift procedure on Long Island under local anesthesia. In fact, Dr. Schiff recently celebrated the successful treatment of his 100th Urolift patient. “Men no longer have to tolerate and suffer from an enlarged prostate. The Urolift is an option for relief that is both minimally invasive and highly effective, and I have witnessed time and again its great success among a wide variety of patients.”
The UroLift System has an excellent safety profile and is considered a beneficial first-line treatment alternative to drug therapy or more invasive surgery. Importantly, the UroLift System provides fast and meaningful relief from BPH symptoms, improving overall quality of life for patients. More than 500 million aging men worldwide have an enlarged prostate. Some cases are milder than others, and more serious instances of BPH can significantly impact quality of life and lead to urinary incontinence, kidney or bladder damage, and other issues.
“There really aren’t enough words to describe how I feel today compared to how I felt prior to the procedure, except to say that the entire experience was amazing. I wish I would have done this years ago,” said Mr. Lago.
“This is a major advancement in treating BPH, and I encourage men with an enlarged prostate to explore this revolutionary procedure as a way to provide relief from chronic symptoms that interfere with their daily lives,” added Dr. Schiff.
For more information about Urolift and the vast array of men’s health services at NYU Winthrop-Hospital, call 1-866-WINTHROP or visit www.nyuwinthrop.org.